Completed NA INTERVENTIONAL 4-arm NCT01701102

Study to Find Optimal Dose of Local Spinal Anesthetic (Mepivacaine) Combined With Narcotic (Fentanyl) For Knee Surgery

Optimal Dose of Spinal Mepivacaine Combined With Fentanyl For Knee Arthroscopy

Sponsor: Hospital for Special Surgery, New York

Interventions Mepivacaine Mepivacaine (24 mg) plus fentanyl Mepivacaine (27 mg) plus fentanyl Mepivacaine (30 mg) plus fentanyl

Updated 7 times since 2017 Last updated: Mar 9, 2016 Started: Dec 31, 2011 Primary completion: Jul 31, 2012 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Arthroscopic Knee Surgery and is currently completed. Hospital for Special Surgery, New York leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital for Special Surgery, New York

Data source: Hospital for Special Surgery, New York

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States